Block Acquisition Could Boost SmithKline International Sales By $560 Mil.
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham could boost its international consumer health presence by over 7% as a result of its purchase of niche marketer Block Drug.
You may also be interested in...
Clarke To Oversee Glaxo Consumer Division During Xenical Switch Bid
Glaxo's plan to switch Xenical (orlistat 60 mg) to over-the-counter status for adults only "provides difficulties in the ultimate marketing," incoming Consumer Healthcare president John Clarke allowed
Clarke To Oversee Glaxo Consumer Division During Xenical Switch Bid
Glaxo's plan to switch Xenical (orlistat 60 mg) to over-the-counter status for adults only "provides difficulties in the ultimate marketing," incoming Consumer Healthcare president John Clarke allowed
Clarke To Oversee Glaxo Consumer Division During Xenical Switch Bid
Glaxo's plan to switch Xenical (orlistat 60 mg) to over-the-counter status for adults only "provides difficulties in the ultimate marketing," incoming Consumer Healthcare president John Clarke allowed